baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Финансовые показатели

Новости

TraderScreen

Zealand Pharma A/S/ DK0060257814 /

14.11.2024 16:45:51	Изменение -	Объем сделки	Бид19.07.2024	Предложение19.07.2024	Максимум	Минимум
810.50DKK	-	394 Оборот: 318,388	-Величина цены спроса: -	-Величина цены предложения: -	810.50	804.00

GlobeNewswire 22.08 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

GlobeNewswire 15.08 Zealand Pharma Announces Financial Results for the First Half of 2024

GlobeNewswire 12.08 Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial...

GlobeNewswire 29.07 Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

GlobeNewswire 26.06 Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...

GlobeNewswire 25.06 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...

GlobeNewswire 25.06 Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...

GlobeNewswire 20.06 Zealand Pharma announces positive topline results from the Phase 1b 16-week multiple ascending dose ...

GlobeNewswire 07.06 Zealand Pharma announces that Boehringer Ingelheim’s survodutide demonstrates breakthrough improveme...

GlobeNewswire 07.06 Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsenin...

GlobeNewswire 06.06 Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial ...

GlobeNewswire 31.05 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...

GlobeNewswire 29.05 Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024

GlobeNewswire 23.05 Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low ...

GlobeNewswire 16.05 Zealand Pharma Announces Financial Results for the First Quarter of 2024

GlobeNewswire 09.05 Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial...

GlobeNewswire 20.03 Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatm...

GlobeNewswire 01.03 Zealand Pharma to Participate in TD Cowen’s 44th Annual Health Care Conference

GlobeNewswire 27.02 Zealand Pharma Announces Financial Results for the Full Year 2023

TeleTrader 26.02 Zealand Pharma soars 30% on positive weight-loss drug results

GlobeNewswire 26.02 Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated ...

GlobeNewswire 26.02 Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver dise...

GlobeNewswire 20.02 Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financia...

GlobeNewswire 19.01 Zealand Pharma major shareholder announcement: J O Hambro Capital Management

GlobeNewswire 17.01 Zealand Pharma major shareholder announcement: J O Hambro Capital Management

Zealand Pharma A/S/ DK0060257814 /

Если вы хотите получить ответ на свой отзыв, укажите, пожалуйста, адрес своей электронной почты.